Teleflex Incorporated TFX
Set alert
At close · Oct 30
After hours · Oct 30, 5:05 PM ET
- YTD
- +14.53%
- 1 year
- +11.96%
- Open
- 142.06
- Prev close
- 141.39
- Mkt cap
- 5.92B
- Vol
- 891.27K
- Avg vol
- 724.46K
- EPS
- -8.48
- P/E
- 0.00
- Div yield
- 0.96%
More statistics
- Low
- 138.99
- High
- 142.70
- Forward P/E
- 12.77
- Beta
- 0.83
- Short ratio
- 4.99
- Inst. own
- 114.78%
- Dividend
- 1.36
- Ex-div date
- Aug 13, 2026
- Earnings
- Nov 5, 2026
- 50-d avg
- 131.24
- 200-d avg
- 124.98
- 1y target
- 154.00
5D chart
Signals (106)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 10:10 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:05 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:50 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 9:50 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:45 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 9:45 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 9:40 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 9:35 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:30 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bearish | Oct 29, 3:55 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:50 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:45 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 3:10 PM | 3 days ago |
| RSI: Overbought | Oct 29, 2:55 PM | 3 days ago |
| RSI: Overbought | Oct 29, 2:40 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:20 PM | 3 days ago |
| RSI: Overbought | Oct 29, 1:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 1:50 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:45 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:45 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:15 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:10 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:10 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:05 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:55 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:45 AM | 3 days ago |
| RSI: Overbought | Oct 29, 11:15 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:00 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:15 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:10 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:45 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:30 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:25 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:30 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:40 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:15 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:10 PM | 4 days ago |
| RSI: Oversold | Oct 28, 12:05 PM | 4 days ago |
| SMA: Bearish | Oct 28, 10:55 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:40 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:30 AM | 4 days ago |
| RSI: Overbought | Oct 28, 10:05 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:40 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:40 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:35 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 4 days ago |
| RSI: Overbought | Oct 27, 3:55 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 3:40 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:35 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:35 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:30 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:25 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:20 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:15 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:05 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:05 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:00 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:45 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:40 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:35 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:05 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:00 PM | 5 days ago |
| RSI: Overbought | Oct 27, 1:35 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:25 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:20 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:05 PM | 5 days ago |
| SMA: Bearish | Oct 27, 11:40 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:50 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:35 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:15 AM | 5 days ago |
| RSI: Oversold | Oct 27, 9:35 AM | 5 days ago |
| SMA: Bearish | Oct 26, 3:35 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 3:20 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:15 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:10 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:10 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:05 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:05 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:50 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:30 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:15 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:25 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:25 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 12:25 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:05 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:00 PM | 6 days ago |
| SMA: Bullish | Oct 26, 11:50 AM | 6 days ago |
| SMA: Bearish | Oct 26, 11:45 AM | 6 days ago |
| SMA: Bullish | Oct 26, 11:15 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:50 AM | 6 days ago |
| SMA: Bullish | Oct 26, 10:45 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:35 AM | 6 days ago |
News
-
1 week ago benzinga.com
Teleflex Receives FDA Breakthrough Device Designation For Its Freesolve Resorbable Magnesium Scaffold For Percutaneous Coronary Intervention
To qualify for a BDD, device technology must address an unmet clinical need and show that it has the potential to provide for more effective treatment of life-threatening diseases or irreversibly…
1 week ago businesswire.com
Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium Scaffold
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted…
1 week ago businesswire.com
Teleflex Announces Third Quarter 2026 Earnings Conference Call Information
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on…
-
2 weeks ago benzinga.com
Truist Securities Maintains Hold on Teleflex, Lowers Price Target to $142
Truist Securities analyst Richard Newitter maintains Teleflex (NYSE:TFX) with a Hold and lowers the price target from $150 to $142.
-
2 weeks ago benzinga.com
Teleflex Completes Patient Enrollment In BIOMAG-LL Clinical Study, Evaluating Freesolve RMS In 35 mm And 40 mm Lengths For Treatment Of De Novo Coronary Lesions Up To 38 mm
102 patients enrolled across 14 European centers to assess safety and clinical performance of 35 mm and 40 mm Freesolve™ Resorbable Magnesium Scaffolds in long coronary lesionsTeleflex Incorporated…
2 weeks ago businesswire.com
Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the successful completion of patient enrollment in the BIOMAG™-LL…
3 weeks ago benzinga.com
Full Transcript: Teleflex Q2 2026 Earnings Call
Teleflex (NYSE:TFX) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you by…
3 weeks ago zacks.com
TFX or SONVY: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and SONOVA HOLDING (SONVY). But which of these two stocks offers value investors a better bang for their…
3 weeks ago zacks.com
Is It Prudent to Add Teleflex Stock to Your Portfolio Now?
TFX's Vascular growth, Asia expansion and improved leverage support the outlook, but tariffs, input costs and margin pressure remain key risks.
1 month ago benzinga.com
This Nice Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday
Wall Street analysts upgraded Grocery Outlet, NICE and Pinnacle Financial Partners; targets are $15, $150 and $118, respectively.
1 month ago benzinga.com
This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Analysts upgraded STAA, NFLX, SFIX, with ratings moving toward Buy or Neutral and mixed price-target changes.
1 month ago businesswire.com
Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the publication of its latest peer-reviewed study in the American…
1 month ago zacks.com
Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock?
Teleflex (TFX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in…
1 month ago benzinga.com
Nasdaq 100 Sinks, Oil Rallies as Trump Rejects Iran's Hormuz Plan: Stock Market Today
Stocks slipped at midday Monday as oil surged and yields hit a 19-year high after Trump rejected Iran's Hormuz plan; MongoDB tumbled 18%.
1 month ago benzinga.com
This First Solar Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday
Analysts upgraded Royal Caribbean, Park Hotels, First Solar, Teleflex and CF Industries, with several receiving higher price targets.
1 month ago 247wallst.com
Here Are Monday’s Top Wall Street Analyst Research Calls: Applied Digital, Autodesk, Datadog, First Solar, L3Harris Technologies, PepsiCo, Roblox, Snowflake, TeraWulf and More
Wall Street analysts are making bold moves as the third quarter closes, with major calls hitting PepsiCo, Roblox, Snowflake, and a Bitcoin infrastructure stock carrying a price target that will turn…
-
1 month ago benzinga.com
B of A Securities Upgrades Teleflex to Buy, Raises Price Target to $158
B of A Securities analyst Craig Bijou upgrades Teleflex (NYSE:TFX) from Neutral to Buy and raises the price target from $145 to $158.
1 month ago zacks.com
Here's Why Teleflex (TFX) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
1 month ago zacks.com
5 Low P/B Stocks That Offer Attractive Value and Growth
TFX, CNC, ENS, ROCK and FAF stand out among five low P/B stocks offering attractive value and promising growth prospects.
1 month ago defenseworld.net
VIRGINIA RETIREMENT SYSTEMS ET Al Acquires New Shares in Teleflex Incorporated $TFX
VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Teleflex Incorporated (NYSE: TFX) in the second quarter, according to its most recent filing with the Securities and Exchange Commission…
1 month ago defenseworld.net
Teleflex Incorporated $TFX Shares Sold by Amundi
Amundi lowered its position in Teleflex Incorporated (NYSE: TFX) by 70.7% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm…
1 month ago zacks.com
TFX vs. PEN: Which Stock Is the Better Value Option?
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks is more attractive to value investors?
1 month ago businesswire.com
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the appointment of Sean M. Salmon to its Board of Directors,…
1 month ago defenseworld.net
Public Employees Retirement System of Ohio Makes New Investment in Teleflex Incorporated $TFX
Public Employees Retirement System of Ohio purchased a new stake in Teleflex Incorporated (NYSE: TFX) in the undefined quarter, according to its most recent disclosure with the Securities and…
1 month ago businesswire.com
Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it will showcase innovative technologies at CIRSE 2026 in…
2 months ago defenseworld.net
Bank of New York Mellon Corp Invests $33.36 Million in Teleflex Incorporated $TFX
Bank of New York Mellon Corp purchased a new position in Teleflex Incorporated (NYSE: TFX) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and…
2 months ago zacks.com
Should You Add Teleflex Stock to Your Portfolio Now?
TFX's Vascular growth, Interventional expansion and improved leverage support its outlook, while currency volatility remains a key risk.
2 months ago zacks.com
TFX or PEN: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two companies is the best option for those looking for undervalued…
2 months ago zacks.com
Is TFX a Buy Now as Valuation Improves but Execution Risks Remain?
Valuation is improving for Teleflex, but slower Vascular Intervention integration and margin pressure keep execution risks in focus.
2 months ago benzinga.com
Nvidia To Rally More Than 8%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts upgraded and raised price targets for FLNC, DT, NVDA, SNOW, TFX, COIN, and EXPE. See how other analysts view these stocks.
-
2 months ago benzinga.com
Needham Maintains Buy on Teleflex, Raises Price Target to $170
Needham analyst Mike Matson maintains Teleflex (NYSE:TFX) with a Buy and raises the price target from $159 to $170.
-
2 months ago benzinga.com
UBS Maintains Neutral on Teleflex, Raises Price Target to $158
UBS analyst Patrick Wood maintains Teleflex (NYSE:TFX) with a Neutral and raises the price target from $145 to $158.
-
2 months ago benzinga.com
Truist Securities Maintains Hold on Teleflex, Raises Price Target to $150
Truist Securities analyst Ravi Misra maintains Teleflex (NYSE:TFX) with a Hold and raises the price target from $143 to $150.
-
2 months ago benzinga.com
Piper Sandler Reiterates Overweight on Teleflex, Raises Price Target to $169
Piper Sandler analyst Jason Bednar reiterates Teleflex (NYSE:TFX) with a Overweight and raises the price target from $160 to $169.
-
2 months ago benzinga.com
Teleflex Raises FY2026 Adj EPS Guidance from $6.25-$6.55 to $6.90-$7.20 vs $6.68 Est; Lowers FY2026 Sales Guidance from $2.280B-$2.300B to $2.260B-$2.280B vs $2.287B Est
Teleflex (NYSE:TFX) raises FY2026 Adj EPS guidance from $6.25-$6.55 to $6.90-$7.20 vs $6.68 analyst estimate. Lowers FY2026 sales outlook from $2.280 billion-$2.300 billion to $2.260 billion-$2.280…
-
2 months ago benzinga.com
Teleflex Q2 Adj. EPS $1.76 Beats $1.28 Estimate, Sales $570.332M Beat $559.596M Estimate
Teleflex (NYSE:TFX) reported quarterly earnings of $1.76 per share which beat the analyst consensus estimate of $1.28 by 37.5 percent. This is a 52.82 percent decrease over earnings of $3.73 per…
-
3 months ago benzinga.com
Needham Maintains Buy on Teleflex, Raises Price Target to $159
Needham analyst Mike Matson maintains Teleflex (NYSE:TFX) with a Buy and raises the price target from $147 to $159.
-
3 months ago benzinga.com
UBS Initiates Coverage On Teleflex with Neutral Rating, Announces Price Target of $145
UBS analyst Patrick Wood initiates coverage on Teleflex (NYSE:TFX) with a Neutral rating and announces Price Target of $145.
-
3 months ago benzinga.com
Teleflex Awarded National Premier Contract for Central Venous, Arterial and Intraosseous Access Devices
Teleflex Incorporated (NYSE:TFX) has been awarded a national group purchasing agreement for central venous access products with Premier, Inc. Effective July 1, 2026, the new agreement allows Premier…
-
3 months ago benzinga.com
Mizuho Maintains Neutral on Teleflex, Raises Price Target to $145
Mizuho analyst Anthony Petrone maintains Teleflex (NYSE:TFX) with a Neutral and raises the price target from $140 to $145.
-
3 months ago benzinga.com
BMO Capital Initiates Coverage On Teleflex with Outperform Rating, Announces Price Target of $159
BMO Capital analyst Vik Chopra initiates coverage on Teleflex (NYSE:TFX) with a Outperform rating and announces Price Target of $159.
-
4 months ago benzinga.com
Teleflex Starts Enrollment For Its BIOMAG‑IIII Study Evaluating The Freesolve Resorbable Magnesium Scaffold
Dr. Itsik Ben-Dor, MedStar Health in Washington, D.C., is the first implanter in the United States (U.S.) in the IDE trial of Freesolve™ RMS. Designed as a pivotal trial to support future regulatory…
-
4 months ago benzinga.com
Teleflex Presents 4‑Yr Follow‑Up Data From First-in-Human BIOMAG-I Clinical Study At EuroPCR Conference
Persistently Low Target Lesion Failure and No New Cardiac-Related EventTeleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the four‑year follow‑up…
-
4 months ago benzinga.com
Piper Sandler Upgrades Teleflex to Overweight, Raises Price Target to $160
Piper Sandler analyst Matt O'Brien upgrades Teleflex (NYSE:TFX) from Neutral to Overweight and raises the price target from $140 to $160.
-
5 months ago benzinga.com
Teleflex Commences $500M Senior Notes Due 2032 Offering
Teleflex Incorporated (NYSE: TFX) ("Teleflex") announced today the commencement of a private offering of $500.0 million aggregate principal amount of senior notes due 2032 (the "Notes"), subject to…
-
5 months ago benzinga.com
Teleflex Says Interventional Urology Business Unit Releases New Clinical Data Across Two Major Urological Congresses, Reinforcing Value Of UroLift System And Barrigel Rectal Spacer In Improving Patient-Centered Outcomes
First Head-to-Head Randomized Control Study (RCT) Reinforces Early Patient Experience Benefits and 12-month Durability of the UroLift™ System versus Rezūm™Three-Year Data Demonstrate Sustained…
-
5 months ago benzinga.com
Truist Securities Reiterates Hold on Teleflex, Raises Price Target to $143
Truist Securities analyst Ravi Misra reiterates Teleflex (NYSE:TFX) with a Hold and raises the price target from $135 to $143.
-
5 months ago benzinga.com
RBC Capital Upgrades Teleflex to Outperform, Raises Price Target to $155
RBC Capital analyst Shagun Singh upgrades Teleflex (NYSE:TFX) from Sector Perform to Outperform and raises the price target from $135 to $155.
-
5 months ago benzinga.com
Wells Fargo Maintains Equal-Weight on Teleflex, Raises Price Target to $138
Wells Fargo analyst Larry Biegelsen maintains Teleflex (NYSE:TFX) with a Equal-Weight and raises the price target from $130 to $138.
-
5 months ago benzinga.com
Teleflex Affirms FY2026 Adj EPS Guidance of $6.25-$6.55 vs $6.72 Est
Teleflex (NYSE:TFX) affirms FY2026 Adj EPS guidance from $6.25-$6.55 to $6.25-$6.55 vs $6.72 analyst estimate. Affirms FY2026 sales outlook from $2.280 billion-$2.300 billion to $2.280 billion-$2.300…